Drug Profile
CTC 96
Alternative Names: CTC-96; DoxovirLatest Information Update: 21 Apr 2011
Price :
$50
*
At a glance
- Originator Redox Pharmaceutical
- Developer OPKO Health; Redox Pharmaceutical
- Class Antivirals; Nonsteroidal anti-inflammatories; Organometallic compounds; Small molecules
- Mechanism of Action Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Herpes simplex virus infections; Infectious keratoconjunctivitis